Page last updated: 2024-09-04

sodium salicylate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

sodium salicylate has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Compound Research Comparison

Studies
(sodium salicylate)
Trials
(sodium salicylate)
Recent Studies (post-2010)
(sodium salicylate)
Studies
(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
Trials
(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
2,031501713,85981,052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohanakumar, KP; Muralikrishnan, D; Thomas, B1

Other Studies

1 other study(ies) available for sodium salicylate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
    Brain research, 2000, May-12, Volume: 864, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Cyclooxygenase Inhibitors; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Free Radical Scavengers; Gentisates; Glutathione; Homovanillic Acid; Hydroxybenzoates; Hydroxyl Radical; Male; Mice; Mice, Inbred BALB C; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neuroprotective Agents; Sodium Salicylate; Substantia Nigra

2000